chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Expired dose given to patient; It was taken out of the freezer and placed in the refrigerator on 29-Jan-2022. The vial was punctured on 02-Feb-2022 at 10:00 AM; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose given to patient) and PRODUCT STORAGE ERROR (It was taken out of the freezer and placed in the refrigerator on 29-Jan-2022. The vial was punctured on 02-Feb-2022 at 10:00 AM ) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose given to patient) and PRODUCT STORAGE ERROR (It was taken out of the freezer and placed in the refrigerator on 29-Jan-2022. The vial was punctured on 02-Feb-2022 at 10:00 AM ). On 03-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Expired dose given to patient) and PRODUCT STORAGE ERROR (It was taken out of the freezer and placed in the refrigerator on 29-Jan-2022. The vial was punctured on 02-Feb-2022 at 10:00 AM ) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that an excursion where product was administered 27 hours after the vial was punctured. The Moderna vial, Lot # 022J21A , was taken out of the freezer and placed in the refrigerator on 29-Jan-2022. The vial was punctured on 02-Feb-2022 at 10:00 AM and a doses was administered on 03-Feb-2022 between 10 am and 1pm. The punctured vial remained at room temperature.  No treatment medications were reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives on hands and feet/hives on knees, behind knees; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on hands and feet/hives on knees, behind knees) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives on hands and feet/hives on knees, behind knees). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at a dose of 10 milligram and CORTISONE for Adverse event, at a dose of 1% cream. At the time of the report, URTICARIA (hives on hands and feet/hives on knees, behind knees) had not resolved.            Concomitant medications were not reported. Treatment medications  includes Anti histamines.   This case was linked to MOD-2022-476856 (Patient Link).
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccination interval betwwen 1st dose and 2nd dose was more than 25-35 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccination interval betwwen 1st dose and 2nd dose was more than 25-35 days) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD (start date can be 5 or 6.) since March 2020. Concomitant products included OMEPRAZOLE (OMEPRAZOLE DARNITSA) for Acid reflux (oesophageal), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA RESPIMAT) for COPD, SIMVASTATIN (SIMVATATINE) for Cholesterol, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for Cold sores.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccination interval betwwen 1st dose and 2nd dose was more than 25-35 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccination interval betwwen 1st dose and 2nd dose was more than 25-35 days) outcome was unknown.            Patient was not tested positive for COVID-19.  No treatment information was reported.   This case was linked to MOD-2021-062206 (Patient Link).
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Food allergy, Pruritus, Rash
Clinical narrative: allergy to spicy food after the third dose of Moderna vaccine.; skin rashes; Itchiness; This spontaneous case was reported by a non-health professional and describes the occurrence of FOOD ALLERGY (allergy to spicy food after the third dose of Moderna vaccine.), RASH (skin rashes) and PRURITUS (Itchiness) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FOOD ALLERGY (allergy to spicy food after the third dose of Moderna vaccine.), RASH (skin rashes) and PRURITUS (Itchiness). At the time of the report, FOOD ALLERGY (allergy to spicy food after the third dose of Moderna vaccine.), RASH (skin rashes) and PRURITUS (Itchiness) outcome was unknown.            No concomitant medication reported. No treatment information was provided. It was reported that patient does not had underlying disease.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site mass, Vaccination site pain
Clinical narrative: tenderness to the touch at the injection site; golf ball size lump in her arm/the lump has slowly gone away; she has developed some side effects after receiving the 1st shot of the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (she has developed some side effects after receiving the 1st shot of the Moderna COVID-19 vaccine), VACCINATION SITE PAIN (tenderness to the touch at the injection site) and VACCINATION SITE MASS (golf ball size lump in her arm/the lump has slowly gone away) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2022, the patient experienced VACCINATION SITE PAIN (tenderness to the touch at the injection site). In January 2022, the patient experienced VACCINATION COMPLICATION (she has developed some side effects after receiving the 1st shot of the Moderna COVID-19 vaccine) and VACCINATION SITE MASS (golf ball size lump in her arm/the lump has slowly gone away). In January 2022, VACCINATION SITE MASS (golf ball size lump in her arm/the lump has slowly gone away) had resolved. At the time of the report, VACCINATION COMPLICATION (she has developed some side effects after receiving the 1st shot of the Moderna COVID-19 vaccine) and VACCINATION SITE PAIN (tenderness to the touch at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided Treatment medications were not provided Patient should get the second dose which was scheduled on 09-feb-2022. Patient was retired nurse has never seen anything like this before so Patient is having doubts about getting the 2nd dose.   Reporter did not allow further contact
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine dose administered/Dose administered >12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine on 02-Jun-2021 and Pfizer vaccine on 23-Jun-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine.    On 09-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Reporter stated that their facility administered an expired booster dose  of Moderna COVID-19 vaccine to 1 patient. The vaccine was given at 10am EST on 09-Feb-2022 from a vial that expired yesterday, 08-Feb-2022 at11:30pm. She stated that only 1 dose was given from after it was expired which was a booster dose. Dose was administered after 12 hours post puncture. Date the vial was initially stored in the refrigerator was on 08-Feb-2022, Date and time vial was first punctured was on 08-Feb-2022 at 8:30am, Date and time of administration of vaccine was on 09-Feb-2022 at 10am EST, the vial was stored post puncture in Fridge, the vial did not undergo temperature excursions. No treatment information was provided.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine was given to a 15 year old for first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine was given to a 15 year old for first dose) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine was given to a 15 year old for first dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine was given to a 15 year old for first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment drugs were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Feb-2022: Follow up received contains no new information
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria, Vaccination site reaction
Clinical narrative: they started to have and are ongoing ,sever hives, a rash and itchiness; they started to have and are ongoing ,sever hives, a rash and itchiness; they started to have and are ongoing ,sever hives, a rash and itchiness; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (they started to have and are ongoing ,sever hives, a rash and itchiness), PRURITUS (they started to have and are ongoing ,sever hives, a rash and itchiness), VACCINATION SITE REACTION (Covid arm) and RASH (they started to have and are ongoing ,sever hives, a rash and itchiness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21a, 0001a21a and 007b21a) for COVID-19 vaccination.     Concomitant products included TRAZODONE for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE REACTION (Covid arm). On 08-Jan-2022, the patient experienced URTICARIA (they started to have and are ongoing ,sever hives, a rash and itchiness), PRURITUS (they started to have and are ongoing ,sever hives, a rash and itchiness) and RASH (they started to have and are ongoing ,sever hives, a rash and itchiness). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. On 31-Dec-2021, VACCINATION SITE REACTION (Covid arm) had resolved. At the time of the report, URTICARIA (they started to have and are ongoing ,sever hives, a rash and itchiness), PRURITUS (they started to have and are ongoing ,sever hives, a rash and itchiness) and RASH (they started to have and are ongoing ,sever hives, a rash and itchiness) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Allergies (medications, food and other products) : NO Has patient ever had COVID + test or diagnosis?  NO No medical history was reported.   This case was linked to MOD-2022-477308, MOD-2022-477313 (Patient Link).
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Neck pain, SARS-CoV-2 test, Vaccination site erythema, Vaccination site mass
Clinical narrative: Neck pain; Left arm knot at injection site; Left arm knot at injection site, knot also red; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), VACCINATION SITE MASS (Left arm knot at injection site), VACCINATION SITE ERYTHEMA (Left arm knot at injection site, knot also red) and HEADACHE (Headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Feb-2022, the patient experienced NECK PAIN (Neck pain), VACCINATION SITE MASS (Left arm knot at injection site), VACCINATION SITE ERYTHEMA (Left arm knot at injection site, knot also red) and HEADACHE (Headache). At the time of the report, NECK PAIN (Neck pain), VACCINATION SITE MASS (Left arm knot at injection site), VACCINATION SITE ERYTHEMA (Left arm knot at injection site, knot also red) and HEADACHE (Headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had no allergies. The patient had experienced these adverse reactions for the first time and did not experience these adverse reactions with other vaccines.  No treatment medications were reported.   No concomitant medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: COVID arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm after first dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0001a21a) for COVID-19 vaccination.     Concomitant products included TRAZODONE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE REACTION (COVID arm after first dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 16-Mar-2021, VACCINATION SITE REACTION (COVID arm after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient had COVID arm after the first and second doses, but it occur 8 day after each vaccine and lasted for two weeks.   This case was linked to MOD-2022-477285, MOD-2022-477313 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007b21a and 0001a21a) for COVID-19 vaccination.     Concomitant products included TRAZODONE for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. In April 2021, VACCINATION SITE REACTION (Covid arm) had resolved.            Height of the patient was mentioned as 411 and 3/4.  It was reported that the patient experienced Covid arm eight days after the first and second dose and it lasted for two weeks.   This case was linked to MOD-2022-477285, MOD-2022-477308 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Shoulder injury related to vaccine administration
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Syncope, Unresponsive to stimuli
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: PATIENT STOOD UP AND THEN SAID SHE FELT FAINT.  THE IMMUNIZER TOLD HER TO SIT DOWN ON THE CHAIR AND BEFORE SHE COULD TO THIS SHE FAINTED.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: rash not cleared by benadryl on trunk of body, sought medical attention and received steroids
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Electric shock sensation, Paraesthesia
Clinical narrative: Tingling feels like electric shocks inner left foot through toes. Happens sitting standing and walking.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Joint swelling, Rash, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Started out with rash on my upper back , severe fatigue, then joint swelling in fingers of both hands. Same thing happened after booster but no rash.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Migraine, Nausea, Pain
Clinical narrative: Nausea  --daily since Wednesday Exterme body aches --daily since Wednesday Migraines --daily since Wednesday  Extreme tiredness  --daily since Wednesday Dizzy--Wednesday night Pale color--Wednesday night
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor
Clinical narrative: Nausea  --daily since Wednesday Exterme body aches --daily since Wednesday Migraines --daily since Wednesday  Extreme tiredness  --daily since Wednesday Dizzy--Wednesday night Pale color--Wednesday night
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Injection site pain
Clinical narrative: Soreness at injection site, cough and shortness of breath
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscle spasms, Nausea, Pain
Clinical narrative: Fever over 101. Severe chills, body aches, headache, nausea 1 week later I had vaginal bleeding for 3 days with cramping.  Prior to this I had not had a period in over 7 years.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaginal haemorrhage
Clinical narrative: Fever over 101. Severe chills, body aches, headache, nausea 1 week later I had vaginal bleeding for 3 days with cramping.  Prior to this I had not had a period in over 7 years.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Cyanosis, Dehydration, Disorientation, Feeling cold
Clinical narrative: 5 hours after injection Patient started convulsing and lost consciousness. She came to but was very disoriented. Her face was pure pale and her lips were blue.  She then vomited 3 times and was taken by ambulance to the hospital. Her blood pressure dropped too low. She was severely dehydrated and needed fluids. Her body was hot but shaking uncontrollably because she was cold.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Pallor, Seizure, Skin warm, Tremor
Clinical narrative: 5 hours after injection Patient started convulsing and lost consciousness. She came to but was very disoriented. Her face was pure pale and her lips were blue.  She then vomited 3 times and was taken by ambulance to the hospital. Her blood pressure dropped too low. She was severely dehydrated and needed fluids. Her body was hot but shaking uncontrollably because she was cold.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 5 hours after injection Patient started convulsing and lost consciousness. She came to but was very disoriented. Her face was pure pale and her lips were blue.  She then vomited 3 times and was taken by ambulance to the hospital. Her blood pressure dropped too low. She was severely dehydrated and needed fluids. Her body was hot but shaking uncontrollably because she was cold.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Event occurred after dose completion.  Patient was diagnosed with COVID Tylenol In-patient
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccine breakthrough infection
Clinical narrative: Suspect COVID breakthrough case
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, Catheterisation cardiac abnormal, Coronary artery occlusion, Coronary artery stenosis, Cough
Clinical narrative: Patient arrived to emergency department complaining of 3 day history of shortness of breath and coughing. He was found to have significantly elevated BNP and elevated troponins with significant ST depression on EKG. Echo findings included an ejection fraction of 15-20%. Left heart catheterization was performed and found 90% stenosis in left main artery, total occlusion in left circumflex, 99% stenosis in proximal left anterior descending artery, 80% stenosis in mid left anterior descending artery, 50-60% stenosis in proximal right coronary artery, and total occlusion in distal right  coronary artery. Impella device was placed and patient was transferred emergently to outside facility for evaluation for CABG.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram ST segment depression, Troponin increased
Clinical narrative: Patient arrived to emergency department complaining of 3 day history of shortness of breath and coughing. He was found to have significantly elevated BNP and elevated troponins with significant ST depression on EKG. Echo findings included an ejection fraction of 15-20%. Left heart catheterization was performed and found 90% stenosis in left main artery, total occlusion in left circumflex, 99% stenosis in proximal left anterior descending artery, 80% stenosis in mid left anterior descending artery, 50-60% stenosis in proximal right coronary artery, and total occlusion in distal right  coronary artery. Impella device was placed and patient was transferred emergently to outside facility for evaluation for CABG.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Ventricular assist device insertion
Clinical narrative: Patient arrived to emergency department complaining of 3 day history of shortness of breath and coughing. He was found to have significantly elevated BNP and elevated troponins with significant ST depression on EKG. Echo findings included an ejection fraction of 15-20%. Left heart catheterization was performed and found 90% stenosis in left main artery, total occlusion in left circumflex, 99% stenosis in proximal left anterior descending artery, 80% stenosis in mid left anterior descending artery, 50-60% stenosis in proximal right coronary artery, and total occlusion in distal right  coronary artery. Impella device was placed and patient was transferred emergently to outside facility for evaluation for CABG.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Muscle spasms
Clinical narrative: Fever, fatigue, severe chills, sweating, nausea, headache, body aches.  1 1/2 weeks after experiranced vaginal bleeding for approximately 4 days with cramping. Prior to the first vaccine I had not had a period in over 7 years.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vaginal haemorrhage
Clinical narrative: Fever, fatigue, severe chills, sweating, nausea, headache, body aches.  1 1/2 weeks after experiranced vaginal bleeding for approximately 4 days with cramping. Prior to the first vaccine I had not had a period in over 7 years.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Injection site urticaria
Clinical narrative: Significant hives and urticaria at injection site (up and down the same side) on left arm. Noticeable joint and back pain began 6 hours post injection. Noticeable fatigue.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccine breakthrough infection
Clinical narrative: Suspect COVID breakthrough case
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Dehydration, Feeling cold, Hyperhidrosis, Malaise
Clinical narrative: Patient began not feeling well 5 hours after the injection. She became pale and sweaty. She  collapsed on her way into the ER. Her blood pressure dropped too low. She became severely dehydrated. She needed a bag of fluid. Her body was hot. She was shaking uncontrollably because she was cold.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor, Skin warm, Syncope, Tremor
Clinical narrative: Patient began not feeling well 5 hours after the injection. She became pale and sweaty. She  collapsed on her way into the ER. Her blood pressure dropped too low. She became severely dehydrated. She needed a bag of fluid. Her body was hot. She was shaking uncontrollably because she was cold.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nodule, Pain, Pruritus, Skin warm
Clinical narrative: Patient stated she has a knot on her left arm. Itching and warmth at knot. The knot is a little painful. Saw PCP. Her doctor said it appeared to be a delayed reaction to vaccination.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccine breakthrough infection
Clinical narrative: Suspect COVID breakthrough case
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram, Supraventricular extrasystoles
Clinical narrative: Developed a premature heartbeat (PAC) identified in August 2021.
Age: 7.0
Sex: F
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received in error the Flublok by manufacturer Sanofi Pasteur. Physician spoke with patient mother on date of injection in the evening: at this time mother reported no issues. Physician provided mother with her personal cell to call if any questions or issues arise. Office spoke with mother the next day as a check in. Patient mother at this time reported patient seemed more tired that usual. No other adverse effects noted.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Dermatologic examination, Fatigue, Pain in extremity, Thyroid function test normal
Clinical narrative: I had the normal arm soreness and fatigue for a few days. I received my flu vaccine one week prior to my Covid Booster. A couple of weeks after my booster I noticed that I was starting to have significant hair loss and I am continuing to have significant hair loss at the 3 month mark.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated with 2 dose moderna series admitted with COVID on 2/9/22
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Pain in extremity
Clinical narrative: Expired dose of Moderna administered on 02/08/2022. Expiration date of 02/02/2022. No treatment given. Pt reports sore arm at time  of notification of incident.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Feeling abnormal, Heart rate increased
Clinical narrative: After the second dose my heart rate has gone up and I feel not good. I have been miserable. I do not know if it is related or not. I went to the cardiologist and all he did was give me more heart rate medicine. He just did an EKG and they were fine and it was ok to take the medicine. I have been on numerous antibiotics since then. I have been to the emergency room multiple times for the heart rate and they really did not do anything. They just put me back on steroids and antibiotics. I have been hospitalized about 6 times for 10 days for the same thing.
Age: 5.0
Sex: M
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received in error the Flublok by manufacturer Sanofi Pasteur. Physician spoke with patient mother on date of injection in the evening: at this time mother reported no issues. Physician provided mother with her personal cell to call if any questions or issues arise. Office spoke with mother the next day as a check in. Patient mother at this time reported no adverse effects noted.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Event occurred after second dose. Patient was diagnosed with COVID Discharged
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Petechiae
Clinical narrative: Developed severe petechiae on hands within 30 minutes following vaccination.  Developed headache and muscle pain within 6 hours following vaccination.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 11-year-old given a Moderna vaccine; should have been given Pfizer.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Antinuclear antibody negative, C-reactive protein increased, Laboratory test, Myalgia, Pyrexia
Clinical narrative: Generalized urticarial rash with associated fever and myalgias, moderate/severe
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate normal, Urticaria, White blood cell count increased
Clinical narrative: Generalized urticarial rash with associated fever and myalgias, moderate/severe
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna COVID 19 vaccine was given to 16yo
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient received Pfizer COVID-19 vaccine beyond the manufacturer recommended 31 days at refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range, which is supported by the above data. No known adverse outcome.
Age: 5.0
Sex: M
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received in error the Flublok by manufacturer Sanofi Pasteur. Physician spoke with patient mother on date of injection in the evening: at this time mother reported no issues. Physician provided mother with her personal cell to call if any questions or issues arise. Office spoke with mother the next day as a check in and no adverse effects noted.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Enlarged lymph node in armpit.  Rash starting on the back of my neck, left side.  Running down my arm into my armpit on left side only. Extending to the middle of my back. Not itchy at all.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 15-year-old received Moderna vaccine. Parents notified. No adverse events.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Headache
Clinical narrative: Headaches - on and off usually occurs  later in evening
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Throat tightness
Clinical narrative: An hour after receiving vaccination throat began to close; unable to speak.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse events at this time.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Asthenia, Joint range of motion decreased, Muscle spasms, Pain
Clinical narrative: Inflammation in right shoulder where humoral and biceps ligaments/tendons articulate. Pain, constant, now chronic muscle cramping and weakness. Same happened in left arm after booster dose in Nov. 2021. Both injections were very painful and have resulted in now chronic pain and weakness that are limiting my strengths and range of motion.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray limb
Clinical narrative: Inflammation in right shoulder where humoral and biceps ligaments/tendons articulate. Pain, constant, now chronic muscle cramping and weakness. Same happened in left arm after booster dose in Nov. 2021. Both injections were very painful and have resulted in now chronic pain and weakness that are limiting my strengths and range of motion.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Patient death from breakthrough COVID S/p COVID vaccination
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bradycardia, COVID-19, Death, Hyporesponsive to stimuli, Productive cough
Clinical narrative: Patient death from breakthrough COVID S/p COVID vaccination
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulse absent, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Patient death from breakthrough COVID S/p COVID vaccination
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Incorrect dose administered, Malaise, Nausea, Pain in extremity
Clinical narrative: Called mother of patient, on 1/20/22. Informed that daughter received undiluted Pfizer vaccine. MOP expressed daughter had a sore injection site and stomach pain. MOP gave ibuprofen to help with pain. MOP would like to talk to clinician to discuss side effects and incident.   Mother's contact information will be given to Chief Clinical Officer, Dr for a call back. MOP was informed that due to this being daughter's second covid vaccine nothing needs to be done and she can get her booster in 5 months.   Dr. called mother on January 20, 2022. Mother thought it was her menstrual, but it's early for that.   Did give ibuprofen to help with that. Arm is more sore than it was with the first shot. Patient felt nauseous and this has continued.  Patient has been in school today. Mom is going to pick her up now. Mom declined an appointment with Dr. tomorrow afternoon.   Additional follow-up phone call on January 21, 2022  by Dr.  Patient feeling about the same this morning.  Did not feel well, in that her stomach still hurt. Did try to go to the bathroom.  Mom thinks she defecated, but doesn't know if it was diarrhea or not.   Rx with ibuprofen.  Did go to school.  Location of shot not swollen.  Mom has not told patient of vaccine high dose so as not to worry her. Offered to call mom tomorrow to check in.  And reinforced to try to hydrate and call if any questions.    Phone call on January 25, 2022 by MD. Patient getting better, but still having some symptoms.  Mom in class tonight and can't talk now.  Offered to call back tomorrow and talk then .  Mom said "that's fine".   Phone call on January 26, 2022 by MD.  Left message for mom to return my call if she's still having symptoms or wants to talk.    Note on January 27, 2022 No call back received from mother to MD.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Called mother of patient, on 1/20/22. Informed that daughter received undiluted Pfizer vaccine. MOP expressed daughter had a sore injection site and stomach pain. MOP gave ibuprofen to help with pain. MOP would like to talk to clinician to discuss side effects and incident.   Mother's contact information will be given to Chief Clinical Officer, Dr for a call back. MOP was informed that due to this being daughter's second covid vaccine nothing needs to be done and she can get her booster in 5 months.   Dr. called mother on January 20, 2022. Mother thought it was her menstrual, but it's early for that.   Did give ibuprofen to help with that. Arm is more sore than it was with the first shot. Patient felt nauseous and this has continued.  Patient has been in school today. Mom is going to pick her up now. Mom declined an appointment with Dr. tomorrow afternoon.   Additional follow-up phone call on January 21, 2022  by Dr.  Patient feeling about the same this morning.  Did not feel well, in that her stomach still hurt. Did try to go to the bathroom.  Mom thinks she defecated, but doesn't know if it was diarrhea or not.   Rx with ibuprofen.  Did go to school.  Location of shot not swollen.  Mom has not told patient of vaccine high dose so as not to worry her. Offered to call mom tomorrow to check in.  And reinforced to try to hydrate and call if any questions.    Phone call on January 25, 2022 by MD. Patient getting better, but still having some symptoms.  Mom in class tonight and can't talk now.  Offered to call back tomorrow and talk then .  Mom said "that's fine".   Phone call on January 26, 2022 by MD.  Left message for mom to return my call if she's still having symptoms or wants to talk.    Note on January 27, 2022 No call back received from mother to MD.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna Vaccine was given to 15yo
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: covid pna
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Death
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaemia, COVID-19, End stage renal disease, Haematoma, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID during hospital admission for large hematoma, acute blood anemia, ESRD. No respiratory symptoms, supportive care only.  Admitted 1/7/2022, tested positive 1/7/2022.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17yo given Moderna vaccination
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Patient death from breakthrough COVID S/P COVID-19 vaccination
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cautery to nose, Epistaxis
Clinical narrative: Booster received on 12/28/2021 and on 12/31/2021 I started to have a chronic, gushing nosebleed that continued intermittently every few hours for the next seven days.  The nosebleed was very high up, not coming from the front end of my nose.  It would often start gushing down my throat before it even started coming out the front of my nose.  It was very hard to get it to stop bleeding every time.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Parent (who is an ophthalmologist) called 2 days after vaccine was given to state that there appeared to be cellulitis on the arm vaccine was given. Call was taken by my partner. Redness and swelling superior to the injection site that was warm to touch. Dr. started antibiotics for cellulitis after taking phone call.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Hypoxia, Pneumonia
Clinical narrative: Hospitalization 01/08/22-1/27/22 for COVID19, pneumonia, hypoxemia. Treated with baricitinib, dexamethasone, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Balance disorder, Blood test normal, Dizziness
Clinical narrative: Eczema rash, breathing issues, thick sputum that will not stop production, blacking out spells, eye infections that keep coming back, swollen veins under eye lids. As of 02/04/2021 I cannot taste certain foods. I can taste spicy and salty at random.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Eczema, Eye infection, Laboratory test normal, Loss of consciousness
Clinical narrative: Eczema rash, breathing issues, thick sputum that will not stop production, blacking out spells, eye infections that keep coming back, swollen veins under eye lids. As of 02/04/2021 I cannot taste certain foods. I can taste spicy and salty at random.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Phlebitis, Sputum increased, Vision blurred, X-ray normal
Clinical narrative: Eczema rash, breathing issues, thick sputum that will not stop production, blacking out spells, eye infections that keep coming back, swollen veins under eye lids. As of 02/04/2021 I cannot taste certain foods. I can taste spicy and salty at random.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Death
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 15-year-old given the Moderna vaccine.
Age: 34.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Arthralgia, Ear pain, Fatigue, Headache
Clinical narrative: Headache, arm, shoulder, neck, ear and scalp nerve pain and itchiness, exhausted but can't sleep, biting feeling in left heal of foot, joint pain upon use in left shoulder, knee.  Increased all over pain.  Flashes of nerve pain across chest between collar bone and breasts.  Ear pain and everything sounded like an echo for an entire day in my left ear.  Intermittent loss of voice for 2 days.  Muscle spasms from bra line to hip on left side of my back.   Overall worsening of my normal symptoms and pain.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Muscle spasms, Neuralgia, Pain, Pain in extremity
Clinical narrative: Headache, arm, shoulder, neck, ear and scalp nerve pain and itchiness, exhausted but can't sleep, biting feeling in left heal of foot, joint pain upon use in left shoulder, knee.  Increased all over pain.  Flashes of nerve pain across chest between collar bone and breasts.  Ear pain and everything sounded like an echo for an entire day in my left ear.  Intermittent loss of voice for 2 days.  Muscle spasms from bra line to hip on left side of my back.   Overall worsening of my normal symptoms and pain.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Tinnitus
Clinical narrative: Headache, arm, shoulder, neck, ear and scalp nerve pain and itchiness, exhausted but can't sleep, biting feeling in left heal of foot, joint pain upon use in left shoulder, knee.  Increased all over pain.  Flashes of nerve pain across chest between collar bone and breasts.  Ear pain and everything sounded like an echo for an entire day in my left ear.  Intermittent loss of voice for 2 days.  Muscle spasms from bra line to hip on left side of my back.   Overall worsening of my normal symptoms and pain.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardiac failure congestive
Clinical narrative: Hospitalization for COVID, CHF 1/10/22-1/18/22. Treated with baricitinib, dexamethasone, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 16-year-old received Moderna vaccine. No adverse outcome.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Hospitalization
Age: 58.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: No adverse event.  Medication Error:  Too little diluent 1.3ml diluent mixed with adult Pfizer Covid-19 vaccine when correct dosage should have been 1.8mL.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Hospitalization for COVID PNA 1/9/22-1/14/22. Treated with dexamethasone, Remdesivir, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Deafness, Ear discomfort, Fatigue, Headache
Clinical narrative: Loss of hearing. Muscle pain in lower back and legs. Chest pain.  Consistent fatigue. Headache. Eye Pressure with occasional splotchy eyesight